Cerus Corporation

World Rank (Jan-05-2024)

14,465

Market Cap (Jan-05-2024)

0.370 Billion USD

World Rank (Jul-30-2023)

12,327

Market Cap (Jul-30-2023)

0.533 Billion USD

World Rank (Jan-07-2022)

9,202

Market Cap (Jan-07-2022)

1.035 Billion USD

World Rank (Jan-01-2021)

7,362

Market Cap (Jan-01-2021)

1.157 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

CERS

Market Cap (Mar-08-2026)

0.37

Employee Count

254

Employee Count as of Date

As on 2020

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

162 Million USD

Annual Operating Income in USD

-34 Million USD

Annual Net Income in USD

-43 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

218 Million USD

Total Liabilities in USD

149 Million USD

Total Equity in USD

69 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Healthcare

Medical Equipment / Instruments

Company Website

Yahoo

Company Profile

Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products and late stage clinical development company. It develops and supplies vital technologies and pathogen protected blood components to blood centers, hospitals and ultimately patients rely on safe blood. The company annual revenue is 24.6 million USD and 240 employees as on 2020. The headquarters is in USA.

Founded Year

1991

IPO Year

1997

Stock Exchange

Nasdaq

Nasdaq Sector

Technology

Nasdaq Industry

EDP Services